2-{[(2-chlorophenyl)methyl]sulfanyl}-4-(2,4-difluorophenoxy)-5,6,7,8-tetrahydroquinazoline

Catalog No. :
ACKEVF450
CAS No. :
339019-34-0
Molecular Formula :
C21H17ClF2N2OS
Molecular Weight :
418.90

IUPAC Name:2-((2-chlorobenzyl)thio)-4-(2,4-difluorophenoxy)-5,6,7,8-tetrahydroquinazoline

2-{[(2-chlorophenyl)methyl]sulfanyl}-4-(2,4-difluorophenoxy)-5,6,7,8-tetrahydroquinazoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-{[(2-chlorophenyl)methyl]sulfanyl}-4-(2,4-difluorophenoxy)-5,6,7,8-tetrahydroquinazoline
IUPAC Name2-((2-chlorobenzyl)thio)-4-(2,4-difluorophenoxy)-5,6,7,8-tetrahydroquinazoline
Molecular FormulaC21H17ClF2N2OS
Molecular Weight418.90
SMILESFC1=CC=C(OC2=C3CCCCC3=NC(SCC4=CC=CC=C4Cl)=N2)C(F)=C1
InChI KeyAGJRAESZUBGNQW-UHFFFAOYSA-N
Synonym2-[(2-CHLOROBENZYL)SULFANYL]-5,6,7,8-TETRAHYDRO-4-QUINAZOLINYL 2,4-DIFLUOROPHENYL ETHER;2-[(2-CHLOROBENZYL)SULFANYL]-4-(2,4-DIFLUOROPHENOXY)-5,6,7,8-TETRAHYDROQUINAZOLINE;2-{[(2-chlorophenyl)methyl]sulfanyl}-4-(2,4-difluorophenoxy)-5,6,7,8-tetrahydroquinazoline;Quinazoline, 2-[[(2-chlorophenyl)methyl]thio]-4-(2,4-difluorophenoxy)-5,6,7,8-tetrahydro-
CAS No.339019-34-0

Synthetic Route by SureRoute

1. ACKEVF450 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKEVF450 route product structure diagram
    ACKEVF450339019-34-0
Inquiry

2. ACKEVF450 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKEVF450 route product structure diagram
    ACKEVF450339019-34-0
Inquiry

Comments (0)